Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage

Transplantation
G W ByrneJ S Logan

Abstract

We characterize a line of transgenic pigs that express the human complement-regulatory proteins human CD59 and human decay-accelerating factor. These genes, under the control of heterologous promoters, are expressed in a variety of organs, including the vasculature of the heart, kidney, and liver. We demonstrate that moderate levels of these gene products are sufficient to protect peripheral blood cells from human or baboon complement. Using pig to baboon heterotopic heart transplants, we show that expression of these proteins is sufficient to block the complement-mediated damage that is the hallmark of such xenografts, when nontransgenic organs are used. These results indicate that there is significant species specificity of intrinsic complement regulatory protein function. This specificity is evident in transgenic organs in which low levels of human CD59 and human decay-accelerating factor expression significantly effect the humoral immune response that causes xenograft rejection. This result suggests that transgenic organs with high levels of human complement-regulatory protein expression will be sufficient to alleviate the humoral immunological barriers that currently block the use of xenogeneic organs for human transplanta...Continue Reading

References

Apr 1, 1990·The Journal of Experimental Medicine·J L PlattA P Dalmasso
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G M HänschM L Shin
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·W L FodorS P Squinto
Sep 1, 1995·Nature Medicine·E Cozzi, D J White
Jan 15, 1995·Transplantation·R J KaplonJ L Platt
Apr 1, 1993·Transplantation·J R LeventhalA J Matas

❮ Previous
Next ❯

Citations

Feb 9, 2002·Molecular Reproduction and Development·Hiroshi MurakamiTaroh Kinoshita
Jan 1, 1997·Immunologic Research·T TakahashiJ L Platt
Jun 29, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Joel G R WeaverAndrew D Badley
Apr 24, 1999·The Annals of Thoracic Surgery·M YeatmanR D Davis
Feb 4, 1998·Life Sciences·S Saadi, J L Platt
Dec 20, 2000·Transplantation Proceedings·M ShiraishiY Muto
Mar 27, 2001·Transplantation Proceedings·A J CohenM D Stegall
Jan 1, 1998·Transplantation Proceedings·J L Platt
Mar 20, 1999·Transplantation Proceedings·U Galili
May 20, 1999·Transplantation Proceedings·J L Platt
Dec 10, 2003·Theriogenology·Monique C J ParisJill M Shaw
Mar 29, 2000·Theriogenology·J A Piedrahita
Jul 14, 1999·Molecular Immunology·T E Mollnes, A E Fiane
Mar 4, 2000·Molecular Immunology·J L Platt, S Saadi
Feb 26, 1998·Immunopharmacology·M Kirschfink
Jun 6, 2000·Advanced Drug Delivery Reviews·A G MikosJ E Babensee
Sep 28, 2000·Current Opinion in Immunology·J S Logan
Aug 16, 2002·Transplant Immunology·Anja Roos, Mohamed R Daha
Oct 13, 2001·Trends in Cardiovascular Medicine·D A CunninghamG A Langford
Dec 22, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D K CooperUNKNOWN Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation
Apr 3, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Martin J GoddardJohn Wallwork
Jun 26, 2002·Journal of the American College of Surgeons·Gonzalo V Gonzalez-StawinskiRobert Duane Davis
Mar 3, 1998·Journal of the American College of Surgeons·D W Hanto
Apr 17, 1998·Journal of the American College of Surgeons·S S Lin, J L Platt
May 23, 2001·International Immunopharmacology·N Rawal, M K Pangburn
Jul 30, 2002·Allergy·Tom Eirik Mollnes, A E Fiane
Apr 7, 2010·Nature Reviews. Gastroenterology & Hepatology·Anil DhawanRagai R Mitry
Oct 30, 1999·Alimentary Pharmacology & Therapeutics·T M Rahman, H J Hodgson
Feb 15, 2000·The British Journal of Surgery·B SoinP J Friend
Jan 8, 2000·Clinical and Experimental Pharmacology & Physiology·S Saadi, J L Platt
Jan 8, 2000·Clinical and Experimental Pharmacology & Physiology·J S Logan, A Sharma
Jan 8, 2000·Clinical and Experimental Pharmacology & Physiology·J L Platt, T Nagayasu
Feb 15, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·A J TectorJ I Tchervenkov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.